Drug discovery for neglected diseases: View of a public-private partnership

by Chatelain E, Don RAntiparasitic Antibacterial Drug Discovery,  April 2009, Paul M. Selzer (Ed), Wiley-Blackwell.

Summary: In answer to the lack of modern and effective drugs for diseases such as human African trypanosomiasis (HAT; sleeping sickness) and Chagas disease which present no financial viability for the pharmaceutical industry, new models of drug discovery have been developed.
Drug discovery for neglected diseases: View of a public-private partnershipThe Drugs for Neglected Diseases initiative (DNDi) has adopted a model closely related to that of a virtual biotechnology company for identifying and optimizing drug leads.

Click here to download the full manual [PDF]